Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.19 0.0700 +58.33%
ARIA $9.89 2.9100 +41.69%
EPZM $20.10 2.6000 +14.86%
SNSS $1.21 0.1500 +14.15%
BLRX $1.53 0.1700 +12.50%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CCXI $6.50 -0.3900 -5.66%
NWBO $8.11 -0.1900 -2.29%
PGNX $7.67 -0.1600 -2.04%
VBLT $5.31 -0.1100 -2.03%
PFE $32.66 -0.6000 -1.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Estrogen Taken Alone is Linked to Lower Breast Cancer Risk

(Los Angeles Times) Mar 7, 2012 - An analysis finds that women who took the hormone by itself after menopause had a reduced risk of developing breast cancer. But it's not quite that simple.
read article (free registration required) 

Drug Distributor Is Tied to Imports of Fake Avastin

(Wall Street Journal) Mar 7, 2012 - Authorities investigating the importation of low-cost foreign pharmaceuticals into the U.S. have identified a supply chain that may have allowed fake cancer drugs to reach U.S. clinics.
read article (paid subscription required) 

Eisai Inc. Receives Complete Response Letter from U.S. Food and Drug Administration for DACOGEN® (decitabine) for injection sNDA in Acute Myeloid Leukemia

(Morningstar) Mar 6, 2012 - Eisai Inc. today announced that the company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for Dacogen for the treatment of acute myeloid leukemia (AML) in adults 65 years of age or older who are not considered candidates for induction therapy.
read article 

Ahead of the Bell: Oncothyreon Shares Sink

(MSNBC/Associated Press) Mar 6, 2012 - Shares of the biotechnology company Oncothyreon plunged more than 40 percent before the opening bell on world that its most advanced drug candidate, a cancer treatment, will not be released until next year.
read article 

UC Davis Physician Named to National Panel Evaluating How Physicians Are Paid

(UC Davis Health System) Mar 5, 2012 - Richard Kravitz, UC Davis professor of internal medicine, has been named to a newly formed independent commission that will assess how physicians are paid.
read press release 

Doctors Order More X-Rays, Not Fewer, With Computer Access

(Washington Post) March 5, 2012 - In the debate over the high cost of health care, federal policymakers have always claimed that one way to cut costs is for doctors to use electronic medical records and other information technology.
read article (free registration required) 

House Panel Votes to Ax Health Law’s Cost-Cutting Board

(The Hill/Healthwatch blog) Mar 6, 2012 - The House Energy and Commerce Committee voted Tuesday to repeal a controversial cost-cutting panel in President Obama’s healthcare law.
read article 

Slow, Costly Process Stymies Generic Biotech Drugs

(Reuters) Mar 5, 2012 - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
read article 

Roche Has ‘Other Options’ If Illumina Hostile Takeover Fails, Humer Says

(Bloomberg) March 6, 2012 - Roche Holding AG, the Swiss drugmaker that made a $5.7 billion hostile offer for the gene- mapping company Illumina Inc. (ILMN), said it has other options if the deal falls through.
read article 

Nigeria to Import Morphine in Pain Relief Initiative

(New York Times) Mar 5, 2012 - About 177,000 Nigerians die in pain from cancer or AIDS each year, according to Meg O’Brien, director of a new initiative, but the country has imported only two pounds of morphine since 2007.
read article 

Essay: Answers in Medicine Sometimes Lie in Luck By Kent A. Sepkowitz, M.D.

(New York Times) Mar 5, 2012 - Doctors talk about science, but they also believe deeply in chance.
read article 

Chief Medical Officer at The Cancer Institute of New Jersey Honored by National Group Devoted to Advocacy for Women

(CINJ) Mar 5, 2012 - The chief medical officer at The Cancer Institute of New Jersey (CINJ) has been named as one of this year's 30 'Outstanding Women' by the National Council for Research on Women.
read press release 

Lymphoma Research Foundation Launches Website for Anaplastic Large Cell Lymphoma

(Seattle Post-Intelligencer) Mar 5, 2012 - The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding lymphoma research and to serving those touched by the disease – is pleased to announce the launch of a new website for people affected by anaplastic large cell lymphoma (ALCL).
read article 

Colon Cancer Detection Report for NY Released

(Syracuse Post-Standard/Associated Press) Mar 6, 2012 - An American Cancer Society report finds that the percentage of early-stage diagnosis for colon cancer has improved overall for New York state but 17 counties saw an increase in the rate of later-stage colon cancers.
read article 

Delays 'Leading to Cancer Deaths'

(Yahoo! News UK/Press Association) Mar 5, 2012 - Nearly 40% of people who fear they might have cancer delay visiting a doctor because they are worried about what they will find, according to new research.
read article 

ASCO Comments on CMS Proposed Transparency Rule

(ASCO in Action) Mar 5, 2012 - ASCO has submitted comments to the Centers for Medicare & Medicaid Services on the agency's proposed rule on Transparency Reports and Reporting of Physician Ownership or Investment Interests. The draft rule was issued in connection with the Physician Payment Sunshine Act, a provision of the Affordable Care Act.
read article 

Foundation Medicine Announces Collaboration with Array BioPharma

(MarketWatch) Mar 6, 2012 - Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced a collaboration with Array BioPharma.
read article 

Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy

(Yahoo! Finance) Mar 6, 2012 - Abbott announced today that it will collaborate with Merck to evaluate the use of a FISH (fluorescence in situ hybridization)-based companion diagnostic test to aid in the development of a Merck investigational cancer therapy.
read article 

Researchers Form Alliance in Hunt for Cancer Cures

(Boston Globe) Mar 6, 2012 - The two federally designated cancer centers in the Boston area are embarking on an unusual alliance that will combine the research strengths of both organizations to yield new treatments and insights into two highly lethal cancers.
read article (free registration required) 

Consumer Group Claims Coke, Pepsi Contain Carcinogens

(Fox Business/Dow Jones Newswires) Mar 5, 2012 - Testing shows that levels of a carcinogen linked to the caramel coloring chemical in Coca-Cola and Pepsi-Cola are too high and threaten consumers, the group Center for Science in the Public Interest said Monday.
read article 

Millennium Initiates Pivotal Phase 3 Trial of MLN8237 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

(Morningstar) Mar 5, 2012 - Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.
read article 

Why Men Should Consider an Integrative Approach to Prostate Cancer (Part I)

(Huffington Post/The Blog) Mar 5, 2012 - Could men's behavior increase or decrease their chances of getting prostate cancer? And could cancer patients undergoing conventional treatment while combining complementary therapies and a comprehensive lifestyle approach to their health reach a better outcome?
read article 

'Freckles' on His Retina Prompts a Man to Get Himself Tested for Colon Cancer

(Washington Post) Mar 5, 2012 - Richard Cabot, a physician at Massachusetts General Hospital, first reported an association between colon cancer and a certain type of retinal pigmentation in 1935.
read article (free registration required) 

Wilmot Researchers Create New Way to Study Liver Cancer

(URMC) Mar 5, 2012 - Researchers at the University of Rochester Medical Center’s James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver– Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer.
read article 

Moffitt Cancer Center Researchers And Colleagues Find Possible Genetic Keys To Surviving Epithelial Ovarian Cancer

(Moffitt Cancer Center) Mar 6, 2012 - Researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the United States and the United Kingdom have used two genome-wide association studies (GWAS) - one from the U.S. and one from the U.K. - to detect a novel set of genes found to be associated with epithelial ovarian cancer patient survival.
read press release